Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxin

BJU International

Volumn 93, Issue 3, 2004, Pages 336-340

  Apostolidis, A N ^a,b   Yiangou, Y ^a   Brady, C M ^b   Ford, A P ^c   Baecker, P A ^c   Jacques, T S ^d   Freeman, A ^d   Fowler, C J ^b   Anand, P ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c ROCHE BIOSCIENCE   (United States)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Bladder; Capsaicin; Chronic inflammation; Endothelial; Neurogenic; Nitric oxide synthase; Obstruction; Overactivity; Resiniferatoxin

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; POLYCLONAL ANTIBODY; RESINIFERATOXIN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLADDER BIOPSY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HEMATURIA; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROGENIC BLADDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UROTHELIUM;

ADMINISTRATION, INTRAVESICAL; BIOPSY; DITERPENES; DOUBLE-BLIND METHOD; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEUROTOXINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PROSPECTIVE STUDIES; URINARY BLADDER; URINARY BLADDER, NEUROGENIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1342288862     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2003.04611.x     Document Type: Article

References (31)

1. Lazzeri M, Spinelli M, Beneforti P, Zanollo A, Turini D. Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases. Scand J Urol Nephrol 1998; 32: 331-4
2. Silva C, Rio ME, Cruz F. Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia. Eur Urol 2000; 38: 444-52
3. Janzen J, Bersch U, Pietsch-Breitfeld B, Pressler H, Michel D, Bultmann B. Urinary bladder biopsies in spinal cord injured patients. Spinal Cord 2001; 39: 568-70
4. Dupont MC, Spitsbergen JM, Kim KB, Tuttle JB, Steers WD. Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 2001; 166: 1111-8
5. Yiangou Y, Facer P, Ford A et al. Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int 2001; 87: 774-9
6. Ost D, Roskams T, Van Der Aa F, De Ridder D. Topography of the vanilloid receptor in the human bladder: more than just the nerve fibers. J Urol 2002; 168: 293-7
7. Goso C, Piovacari G, Szallasi A. Resiniferatoxin-induced loss of vanilloid receptors is reversible in the urinary bladder but not in the spinal cord of the rat. Neurosci Lett 1993; 162: 197-200
8. Avelino A, Cruz F. Peptide immunoreactivity and ultrastructure of rat urinary bladder nerve fibers after topical desensitization by capsaicin or resiniferatoxin. Auton Neurosci 2000; 86: 37-46
9. Dasgupta P, Chandiramani VA, Beckett A, Scaravilli F, Fowler CJ. The effect of intravesical capsaicin on the suburothelial innervation in patients with detrusor hyper-reflexia. BJU Int 2000; 85: 238-45
10. Brady CM, Apostolidis AN, Harper M et al. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment. BJU Int 2004; 93: 000-000
11. Moncada S, Palmer RM, Higgs EA. Nitric oxide. Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-42
12. Klotz T, Bloch W, Jacobs G, Niggemann S, Engelmann U, Addicks K. Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer. Urology 1999; 54: 416-9
13. Fathian-Sabet B, Bloch W, Klotz T et al. Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder. J Urol 2001; 165: 1724-9
14. Shochina M, Fellig Y, Sughayer M et al. Nitric oxide synthase immunoreactivity in human bladder carcinoma. Mol Pathol 2001; 54: 248-52
15. De Groot CJ, Ruuls SR, Theeuwes JW, Dijkstra CD, Van der Valk P. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 1997; 56: 10-20
16. De Ridder D, Roskams T, Van Poppel H, Baert L. Nitric oxide synthase expression in neurogenic bladder disease: a pilot study. Acta Neurol Belg 1999; 99: 57-60
17. Persson K, Igawa Y, Mattiasson A, Andersson KE. Inhibition of the arginine/nitric oxide pathway causes bladder hyperactivity in the rat. Acta Physiol Scand 1992; 144: 107-8
18. Mevorach RA, Bogaert GA, Kogan BA. Role of nitric oxide in fetal lower urinary tract function. J Urol 1994; 152: 510-4
19. Chichester P, Schroder A, Horan P, Levin RM. Vascular response of the rabbit bladder to chronic partial outlet obstruction. Mol Cell Biochem 2001; 226: 1-8
20. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996; 270: H411-5
21. Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 2000; 102: 3098-103
22. Babaei S, Stewart DJ. Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model. Cardiovasc Res 2002; 55: 190-200
23. Wu HM, Huang Q, Yuan Y, Granger HJ. VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol 1996; 271: H2735-9
24. He H, Venema VJ, Gu X, Venema RC, Marrero MB, Caldwell RB. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 1999; 274: 25130-5
25. Turner KJ, Crew JP, Wykoff CC et al. The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer. Br J Cancer 2002; 86: 1276-82
26. Ghafar MA, Anastasiadis AG, Olsson LE et al. Hypoxia and an angiogenic response in the partially obstructed rat bladder. Lab Invest 2002; 82: 903-9
27. Wiseman OJ, Fowler CJ. The role of the human bladder lamina propria myofibroblast. BJU Int 2003; 91: 89-93
28. Sui GP, Rothery S, Dupont E, Fry CH, Severs NJ. Gap junctions and connexin expression in human suburothelial interstitial cells. BJU Int 2002; 90: 118-29
29. Maggi CA, Lecci A, Santicioli P, Del Bianco E, Giuliani S. Cyclophosphamide cystitis in rats, involvement of capsaicin-sensitive primary afferents. J Auton Nerv Syst 1992; 38: 201-8
30. Yoshimura N, Erdman SL, Snider MW, de Groat WC. Effects of spinal cord injury on neurofilament immunoreactivity and capsaicin sensitivity in rat dorsal root ganglion neurons innervating the urinary bladder. Neuroscience 1998; 83: 633-43
31. de Groat WC, Kawatani M, Hisamitsu T et al. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst 1990; 30 (SuppL): S71-7